The overarching aim of this study was to evaluate the effectiveness over time of government interventions and policy restrictions and the impact of determinants on spread and mortality during the first-wave of the COVID-19 pandemic, globally, regionally and by country-income level, up to 18 May 2020.
Methods:
We created a global database merging World Health Organization daily case reports (from 218 countries/territories) with other socio-demographic and population health measures from 21 January to 18 May 2020. A four-level government policy interventions score (low to very high) was created based on the Oxford Stringency Index.
Results:
Our results support the use of very high government interventions to suppress both COVID-19 spread and mortality effectively during wave one globally compared to other policy levels of control. Similar trends in virus propagation and mortality were observed in all country-income levels and specific regions.
Conclusions:
Rapid implementation of government interventions was needed to contain the first wave of the COVID-19 outbreak and to reduce COVID-19-related mortality.
HolshueMLDeBoltCLindquistS, et al. First case of 2019 novel coronavirus in the United States. New Engl J Med2020;382:929–36.
6.
CucinottaDVanelliM.WHO declares COVID-19 a pandemic. Acta Biomed2020;91:157–60.
7.
PanALiuLWangC, et al. Association of public health interventions with the epidemiology of the COVID-19 outbreak in Wuhan, China. JAMA2020;323:1915–23.
8.
HoneinMAChristieARoseDA, et al. Summary of guidance for public health strategies to address high levels of community transmission of SARS-CoV-2 and related deaths, December 2020. Morb Mortal Wkly Rep2020;69:1860–7.
9.
McCloskeyBZumlaAIppolitoG, et al. Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma. Lancet2020;395:1096–9.
BambraCRiordanRFordJ, et al. The COVID-19 pandemic and health inequalities. J Epidemiol Community Health2020;74:964–8.
12.
KisslerSMTedijantoCGoldsteinE, et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science2020;368:860–8.
13.
AbdollahiEHaworth-BrockmanMKeynanY, et al. Simulating the effect of school closure during COVID-19 outbreaks in Ontario, Canada. BMC Med2020;18:230.
14.
FlaxmanSMishraSGandyA, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature2020;584:257–61.
15.
HaugNGeyrhoferLLondeiA, et al. Ranking the effectiveness of worldwide COVID-19 government interventions. Nat Hum Behav2020;4:1303–12.
16.
PanWKFernándezDTyrovolasS, et al. Heterogeneity in the effectiveness of non-pharmaceutical interventions during the first SARS-CoV2 wave in the United States. Front Public Health2021;9:754696.
17.
NortonAGozaloADLHColombiNF de, et al. The remaining unknowns: a mixed methods study of the current and global health research priorities for COVID-19. BMJ Global Health2020;5:e003306.
18.
ZhangWQianB-Y.Making decisions to mitigate COVID-19 with limited knowledge. TheLancet Infect Dis2020;20:1121–2.
19.
HanETanMMJTurkE, et al. Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe. Lancet2020;396:1525–34.
TyrovolasSTsiampalisTMorenaM, et al. COVID-19 mortality in Europe, by latitude and obesity status: a geo-spatial analysis in 40 countries. Nutrients2022;14:471.
22.
VernacciniL.DohertyB.Marin FerrerM. INFORM Epidemic Risk Index: Support Collaborative Risk Assessment for Health Threats, EUR 29072 EN, Luxembourg: Publications Office of the European Union, 2017. DOI: 10.2760/218424
PhuaJFaruqMOKulkarniAP, et al. Critical care bed capacity in Asian countries and regions. Crit Care Med2020;48:654–62.
28.
IslamNSharpSJChowellG, et al. Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries. BMJ2020;370:m2743.
29.
LauerSAGrantzKHBiQ, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med2020;172:577–82.
30.
GreeneWH.Accounting for excess zeros and sample selection in Poisson and negative binomial regression models, https://papers.ssrn.com/abstract=1293115 (1994, accessed 20 February 2022).
31.
ZhouFYuTDuR, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet2020;395:1054–62.
32.
SchultzeAWalkerAJMacKennaB, et al. Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform. Lancet Respir Med2020;8:1106–20.
33.
HarrisonSLFazio-EynullayevaELaneDA, et al. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis. PLoS Med2020;17:e1003321.
SpiegelhalterDJBestNGCarlinBP, et al. Bayesian measures of model complexity and fit. J R Stat Soc Series B Stat Methodol2002;64:583–639.
36.
Nussbaumer-StreitBMayrVDobrescuAI, et al. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev2020;4:CD013574.
37.
HsiangSAllenDAnnan-PhanS, et al. The effect of large-scale anti-contagion policies on the COVID-19 pandemic. Nature2020;584:262–7.
38.
BlockPHoffmanMRaabeIJ, et al. Social network-based distancing strategies to flatten the COVID-19 curve in a post-lockdown world. Nat Hum Behav2020;4:588–96.
39.
Nunes-VazR.Visualising the doubling time of COVID-19 allows comparison of the success of containment measures. Glob Biosecur. Epub ahead of print 25 March 2020. DOI: 10.31646/gbio.61.
40.
GilbertMPullanoGPinottiF, et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. Lancet2020;395:871–7.
41.
BongC-LBrasherCChikumbaE, et al. The COVID-19 pandemic: effects on low- and middle-income countries. Anesth Analg2020;131:86–92.
42.
ChowdhuryAZJomoKS.Responding to the COVID-19 pandemic in developing countries: lessons from selected countries of the Global South. Development (Rome)2020;63:162–71.
43.
VerhagenMDBrazelDMDowdJB, et al. Forecasting spatial, socioeconomic and demographic variation in COVID-19 health care demand in England and Wales. BMC Med2020;18:203.
44.
LazzeriniMBarbiEApicellaA, et al. Delayed access or provision of care in Italy resulting from fear of COVID-19. Lancet Child Adolesc Health2020;4:e10–1.
45.
KraemerMUGYangC-HGutierrezB, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science2020;368:493–7.
46.
XiongNWangTLinZ.Invisible spread of SARS-CoV-2. Lancet Infect Dis2020;20:1011–2.
47.
XuSLiY.Beware of the second wave of COVID-19. Lancet2020;395:1321–2.
48.
KandelNChungongSOmaarA, et al. Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries. Lancet2020;395:1047–53.
49.
DronLKalatharanVGuptaA, et al. Data capture and sharing in the COVID-19 pandemic: a cause for concern. Lancet Digit Health2022;4: e748–e756.
50.
BarberRMFullmanNSorensenRJD, et al. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet2017;390:231–66.
51.
UdugamaBKadhiresanPKozlowskiHN, et al. Diagnosing COVID-19: the disease and tools for detection. ACS Nano2020;14:3822–35.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
